製品名:N-Benzyl-3-aminopropan-1-ol

IUPAC Name:3-(benzylamino)propan-1-ol

CAS番号:4720-29-0
分子式:C10H15NO
純度:97%
カタログ番号:CM343598
分子量:165.24

包装単位 有効在庫 価格(USD) 数量
CM343598-25g in stock Ȑŵ
CM343598-100g in stock ƃƿȯ

研究開発用専用.

問い合わせフォーム

   refresh    

製品詳細

CAS番号:4720-29-0
分子式:C10H15NO
融点:-
SMILESコード:OCCCNCC1=CC=CC=C1
密度:
カタログ番号:CM343598
分子量:165.24
沸点:
MDL番号:MFCD00020622
保管方法:

Category Infos

Benzenes
Benzene is an important organic compound with the chemical formula C6H6, and its molecule consists of a ring of 6 carbon atoms, each with 1 hydrogen atom. Benzene is a sweet, flammable, colorless and transparent liquid with carcinogenic toxicity at room temperature, and has a strong aromatic odor. It is insoluble in water, easily soluble in organic solvents, and can also be used as an organic solvent itself. The ring system of benzene is called benzene ring, and the structure after removing one hydrogen atom from the benzene ring is called phenyl. Benzene is one of the most important basic organic chemical raw materials. Many important chemical intermediates can be derived from benzene through substitution reaction, addition reaction and benzene ring cleavage reaction.

Column Infos

Brensocatib
May 28 2024, Insmed announced positive topline results from landmark ASPEN study of Brensocatib in patients with bronchiectasis.
Brensocatib is a small molecule, oral, reversible inhibitor of dipeptidyl peptidase 1 (DPP1) being developed for the treatment of patients with bronchiectasis, CRSsNP, and other neutrophil-mediated diseases. DPP1 is an enzyme responsible for activating neutrophil serine proteases (NSPs), such as neutrophil elastase, in neutrophils when they are formed in the bone marrow. Brensocatib is an investigational drug product that has not been approved for any indication in any jurisdiction.